|
AUTL
|
Autolus Therapeutics plc
|
US
|
NASDAQ
|
|
AVEO
|
AVEO Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
AVXL
|
Anavex Life Sciences Corp.
|
US
|
NASDAQ
|
|
AZN
|
Astrazeneca PLC
|
US
|
NASDAQ
|
|
BCAB
|
BioAtla, Inc.
|
US
|
NASDAQ
|
|
BCTX
|
BriaCell Therapeutics Corp.
|
US
|
NASDAQ
|
|
BDTX
|
Black Diamond Therapeutics, Inc.
|
US
|
NASDAQ
|
|
BDX
|
Becton, Dickinson and Company
|
US
|
NYSE
|
|
BDXB
|
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B
|
US
|
NYSE
|
|
BEAM
|
Beam Therapeutics Inc.
|
US
|
NASDAQ
|
|
BGNE
|
BeiGene, Ltd.
|
US
|
NASDAQ
|
|
BHVN
|
Biohaven Pharmaceutical Holding Company Ltd.
|
US
|
NYSE
|
|
BIAF
|
bioAffinity Technologies, Inc.
|
US
|
NASDAQ
|
|
BIOC
|
Biocept, Inc.
|
US
|
NASDAQ
|
|
BJDX
|
Bluejay Diagnostics, Inc.
|
US
|
NASDAQ
|
|
BLCM
|
Bellicum Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
BMEA
|
Biomea Fusion, Inc.
|
US
|
NASDAQ
|
|
BMRN
|
BioMarin Pharmaceutical Inc.
|
US
|
NASDAQ
|
|
BNOX
|
Bionomics Limited
|
US
|
NASDAQ
|
|
BNR
|
Burning Rock Biotech Limited
|
US
|
NASDAQ
|